Old Dominion Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.65M Buy
37,960
+450
+1% +$19.9K 0.35% 72
2021
Q2
$1.6M Buy
37,510
+200
+0.5% +$8.41K 0.34% 74
2021
Q1
$1.44M Buy
37,310
+600
+2% +$22.7K 0.34% 75
2020
Q4
$1.32M Buy
36,710
+5,750
+19% +$207K 0.33% 73
2020
Q3
$1.18M Buy
30,960
+9,750
+46% +$376K 0.33% 65
2020
Q2
$745K Buy
+21,210
New +$764K 0.23% 77

Other funds holding BSX

Old Dominion Capital Management's BSX Position: Q3 2021 in Review

Old Dominion Capital Management increased its Boston Scientific (BSX) stake by 1.2% in Q3 2021, buying an estimated $19.9K and bringing the position to 37,960 shares worth $1.65M. The position accounts for 0.35% of the portfolio, ranked #72.

Old Dominion Capital Management first reported a position in BSX in Q2 2020 and has held it in 6 quarters since. 877 funds tracked by Wall St. Rank hold BSX as of Q3 2021.

  • Old Dominion Capital Management held 37,960 shares of Boston Scientific worth $1.65M as of Q3 2021.
  • Old Dominion Capital Management bought 450 Boston Scientific shares in Q3 2021, an estimated $19.9K.
  • Boston Scientific made up 0.35% of Old Dominion Capital Management's portfolio in Q3 2021, its #72 holding.
  • Old Dominion Capital Management first reported a position in Boston Scientific in Q2 2020 and has held it in 6 quarters since.
  • 877 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.

Based on Old Dominion Capital Management's 13F filing for Q3 2021, filed 8 Oct 2021.